-
RESCUE INSULIN INITIATION AFTER NON-INSULIN GLUCOSE-LOWERING THERAPY IN PREGNANCY: A RETROSPECTIVE COHORT STUDY IN CHINA
Aug 11, 2026, 17:16 PM -
THE IMPLICATIONS OF THE MOST-FAVORED-NATION (MFN) POLICY IN THE UNITED STATES (US) ON PHARMACEUTICAL PRODUCTS LAUNCH TIMELINES IN EUROPE
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND REAL-WORLD DISEASE BURDEN AMONG PATIENTS WITH PD-L1-POSITIVE METASTATIC TRIPLE-NEGATIVE BREAST CANCER IN THE FIRST-LINE SETTING
Aug 11, 2026, 17:16 PM -
REAL-WORLD TREATMENT PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
ADHERE-MA: A BOTTOM-UP, LOCALLY SOURCED ESTIMATE OF THE ECONOMIC BURDEN OF MEDICATION NON-ADHERENCE IN MOROCCO
Aug 11, 2026, 17:16 PM -
SOCIETAL COSTS IN DUTCH PHARMACEUTICAL REIMBURSEMENT DOSSIERS: EVIDENCE QUALITY AND IMPACT ON COST-EFFECTIVENESS OUTCOMES OF PRODUCTIVITY LOSSES AND INFORMAL CARE USE
Aug 11, 2026, 17:16 PM -
A SCALABLE PROOF-OF-CONCEPT FRAMEWORK FOR USING ROUTINELY COLLECTED REAL-WORLD DATA IN HEALTH TECHNOLOGY APPRAISALS
Aug 11, 2026, 17:16 PM -
CAPTURING USER PREFERENCES IN HEALTH TECHNOLOGY ASSESSMENT: DEVELOPING MODIFIED MULTI-CRITERIA DECISION ANALYSIS METHODS FOR NICE EXISTING USE HEALTHTECH GUIDANCE
Aug 11, 2026, 17:16 PM -
REPRODUCIBILITY OF AI RECOMMENDATIONS DURING TITLE-ABSTRACT SCREENING: QUANTIFYING DECISION STOCHASTICITY
Aug 11, 2026, 17:16 PM -
MULTIMORBIDITY AND THE ECONOMIC BURDEN OF OUT-OF-POCKET HEALTHCARE EXPENDITURE IN OLDER EUROPEAN ADULTS
Aug 11, 2026, 17:16 PM -
DELIVERED IN AN HOUR, BUT AT WHAT COST? THE SILENT COSTS OF AI IN HEOR AND THE CASE FOR OUTCOME-BASED PRICING
Aug 11, 2026, 17:16 PM -
INFORMING VALUE-BASED PROCUREMENT DECISIONS THROUGH SOCIAL RETURN ON INVESTMENT: THE CASE OF IMMUNOGLOBULIN THERAPY IN PRIMARY IMMUNODEFICIENCIES
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF CONNECTED INJECTION DEVICE FOR PAEDIATRIC GROWTH HORMONE DEFICIENCY IN UNITED KINGDOM: A SCENARIO-BASED MICROSIMULATION ANALYSIS USING REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
FACTORS ASSOCIATED WITH REPEAT HCPCS REVIEW CYCLES AMONG EMERGING MEDICAL TECHNOLOGIES
Aug 11, 2026, 17:16 PM -
ASSESSING TIME-VARYING TREATMENT EFFECTS USING FRACTIONAL POLYNOMIAL NETWORK META-ANALYSIS OF SURVIVAL OUTCOMES
Aug 11, 2026, 17:16 PM -
VALIDATION OF HEALTHCARE COST DRIVERS IN OMOP-MAPPED DATA VS. SOURCE CPRD-HES FOR A COHORT OF WOMEN WITH FRAGILITY FRACTURES IN ENGLAND
Aug 11, 2026, 17:16 PM -
A MATHEMATICAL APPRAISAL OF THE FAMILY AND CAREGIVING EFFECTS FRAMEWORK IN MODELING CAREGIVER SPILLOVER EFFECTS
Aug 11, 2026, 17:16 PM -
EXPLORING BARRIERS TO SHARED DECISION-MAKING (SDM) IN RARE DISEASES FROM THE PHYSICIAN PERSPECTIVE IN EUROPE: FINDINGS FROM A CROSS-SECTIONAL SURVEY
Aug 11, 2026, 17:16 PM -
THE ECONOMIC BURDEN OF EARLY-STAGE HR+/HER2- BREAST CANCER (BC) IN SPAIN: A COST-OF-ILLNESS STUDY
Aug 11, 2026, 17:16 PM -
EMA VS FDA APPROVALS OF INNOVATIVE MEDICINES: A SYSTEMATIC ANALYSIS OF APPROVAL EXCLUSIVITY, APPROVAL SEQUENCING, REGULATORY TIMELINES (2021-2026)
Aug 11, 2026, 17:16 PM
